Vivier Pharma Inc. has designed a unique "drug delivery system" called IntraDermal System - IDSTM!
The most important feature of their IntraDermal System - IDSTM is its ability to increase drug flux across the stratum corneum (the true skin) by diffusion and thereby changing the ability of the drug to penetrate the intercellular space i.e., "depot / retention" effect in the layers of the skin (stratum corneum, epidermis and dermis). Why is this "depot / retention effect" so important? This unique "depot / retention" effect in the layers of the skin can improve a drug's or simply a moisturizer's efficiency while significantly reducing its systemic absorption (into the bloodstream). | | What makes these products unique and superior to existing topical products? Often, formulation development of a topical product is based on maximizing the flux across the skin only rather than optimizing drug delivery to the target site. The IntraDermal System - IDSTM formulations penetrate in a controlled manner in the layers of the skin. Vivier has designed products in their novel "drug delivery system" called IntraDermal System - IDSTM to do even more! Their IntraDermal System - IDSTM is designed to penetrate in a controlled manner and to deposit an active ingredient into the skin of the affected area and to moisturize the damaged area of the skin. *Source - Vivier Pharma Inc. brochure and website. |